Skip to content

Analgesic effect of liposomal bupivacaine interscalene brachial plexus block for 72 hours after shoulder arthroscopy: a retrospective analysis

Analgesic effect of liposomal bupivacaine interscalene brachial plexus block for 72 hours after shoulder arthroscopy: a retrospective analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600125295
Enrollment
Unknown
Registered
2026-05-25
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain After Shoulder Arthroscopy

Interventions

0.375% ropivacaine group:None

Sponsors

Jiangsu Province Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >=18 years old; 2. ASA physical status ?-?; 3. Elective unilateral shoulder arthroscopy; 4. The anesthesia record clearly documents that the patient received an ultrasound-guided interscalene brachial plexus block with either liposomal bupivacaine 133mg or 0.375% ropivacaine 15ml; 5. Complete clinical data available for postoperative 72-hour pain assessment.

Exclusion criteria

Exclusion criteria: 1. Long-term use of opioids or sedative medications preoperatively; 2. Allergy to study-related drugs (including bupivacaine, ropivacaine, or opioids); 3. Severe neurological or psychiatric disorders that prevent adequate pain assessment; 4. Failed interscalene brachial plexus block; 5. Bilateral shoulder surgery or conversion to open surgery.

Design outcomes

Primary

MeasureTime frame
Area under the curve (AUC) of resting pain NRS score within 72 hours postoperatively;

Secondary

MeasureTime frame
Opioid consumption within 72 hours postoperatively;The worst NRS score of pain during movement within 72 hours postoperatively;Postoperative sleep disturbance score;Incidence of adverse events related to nerve block;

Countries

China

Contacts

Public ContactMa Guangyu

Jiangsu Province Hospital of Chinese Medicine

774171211@qq.com+86 198 2609 1677

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026